Literature DB >> 178842

Mechanism of localization of 99mTc-labeled pyrophosphate and tetracycline in infarcted myocardium.

M K Dewanjee, P C Kahn.   

Abstract

The gross and subcellular localizations of 99mTc-labeled pyrophosphate and tetracycline in myocardial infarcts were studied in a rabbit model. Experiments utilizing double-nuclide labeling were carried out using a useful mapping technique. Concentration of the various chelates decreases in an expected manner from the center of the infarcted area toward its periphery, but it is higher near the epicardial surface than toward the endocardium. Technetium-99m-pyrophosphate is concentrated in the same infarcted areas as 45Ca ion or 32P-pyrophosphate, but to a much greater degree. The uptake is dependent on both the degree of necrosis and residual blood flow. Gel filtration experiments with rabbit serum indicate that 99mTc-tagged pyrophosphate, tetracycline, and diphosphonate are mainly protein-bound, whereas 32P-pyrophosphate is not. Subcellular localization studies show that 99mTc-tetracycline and 99mTc-pyrophosphate are bound primarily to soluble protein, and only a small fraction is associated with nuclei, mitochondria, and microsomes. The uptake of technetium chelates in myocardial infarcts may be due to the formation of polynuclear complexes with denatured macromolecules rather than to the deposition of calcium in mitochrondria.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178842

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  Noninvasive detection of cell death: from tracking epitaphs to counting coffins.

Authors:  Jagat Narula; Barry L Zaret
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

2.  Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.

Authors:  L M Buja; A J Tofe; P V Kulkarni; A Mukherjee; R W Parkey; M D Francis; F J Bonte; J T Willerson
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

3.  State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.

Authors:  Vasvi Singh; Rodney Falk; Marcelo F Di Carli; Marie Kijewski; Claudio Rapezzi; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2018-12-19       Impact factor: 5.952

Review 4.  Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.

Authors:  Paco E Bravo; Sharmila Dorbala
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

5.  Ectopic accumulation of 99mTc-HMDP in primary lung cancer in comparison with CT findings.

Authors:  S Yoshida; M Fukumoto; N Yoshimura; K Oobayashi; Y Takada
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

6.  Bone scintigraphy of myositis ossificans in apallic syndrome.

Authors:  Z Szabó; F Ritzl; S Chittima; G A Laszlo; C Neumann
Journal:  Eur J Nucl Med       Date:  1982

7.  Infarct avid imaging study in the radionuclide diagnosis of acute myocardial infarction.

Authors:  R L van Heertum
Journal:  Bull N Y Acad Med       Date:  1981-11

8.  Localization of 99mTc-diphosphonate in a surgical scar: a speculative case report and a review of the literature.

Authors:  J R Prince
Journal:  Eur J Nucl Med       Date:  1979-02-01

9.  Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. II. Subcellular localization of 99Tc-DMS complex in the rat kidney in vivo.

Authors:  N Vanlić-Razumenić; J Petrović
Journal:  Eur J Nucl Med       Date:  1982

10.  Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. III. Subcellular distribution and interaction of 99Tc-DMS complex with macromolecules in rat kidney homogenates in vitro.

Authors:  J Petrović; N Vanlić-Razumenić
Journal:  Eur J Nucl Med       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.